1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with puromycin in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (puromycin) | Trials (puromycin) | Recent Studies (post-2010) (puromycin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 5,828 | 1 | 311 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | puromycin (IC50) |
|---|---|---|---|
| 30S ribosomal protein S6 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S7 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L15 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L10 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L11 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L19 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L1 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L20 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L27 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L28 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L29 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L31 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L32 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L33 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L34 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L35 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L36 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S10 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S11 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S12 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S13 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S16 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S18 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S19 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S20 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S2 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S3 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S4 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S5 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S8 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S9 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L13 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L14 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L16 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L23 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S15 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L17 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L21 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L30 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L6 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S14 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S17 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S1 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L18 | Escherichia coli K-12 | 0.9 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 6.075 | |
| 50S ribosomal protein L2 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L3 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L24 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L4 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L22 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L5 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S21 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L25 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, P; Bricio, T; Cobo, ME; Egido, J; González, E; Hernando, L; Mampaso, FM; Martínez-Montero, JC; Pirotzky, E | 1 |
| Remuzzi, G | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and puromycin
| Article | Year |
|---|---|
Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
Topics: Animals; Cyclosporins; Doxorubicin; Eicosanoids; Glomerular Filtration Rate; Glomerulonephritis; Humans; Kidney Diseases; Nephrosis; Platelet Activating Factor; Puromycin; Rabbits; Rats | 1989 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and puromycin
| Article | Year |
|---|---|
Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist.
Topics: Acetates; Animals; Antibodies, Monoclonal; Disease Models, Animal; Diterpenes; Doxorubicin; Ginkgolides; Immunoenzyme Techniques; In Vitro Techniques; Kidney; Kidney Glomerulus; Lactones; Male; Nephritis, Interstitial; Nephrotic Syndrome; Platelet Activating Factor; Proteinuria; Puromycin; Rats; Rats, Inbred Strains | 1989 |